Correlation Between EUDA Health and Transcode Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both EUDA Health and Transcode Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining EUDA Health and Transcode Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between EUDA Health Holdings and Transcode Therapeutics, you can compare the effects of market volatilities on EUDA Health and Transcode Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in EUDA Health with a short position of Transcode Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of EUDA Health and Transcode Therapeutics.

Diversification Opportunities for EUDA Health and Transcode Therapeutics

0.07
  Correlation Coefficient

Significant diversification

The 3 months correlation between EUDA and Transcode is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding EUDA Health Holdings and Transcode Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Transcode Therapeutics and EUDA Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on EUDA Health Holdings are associated (or correlated) with Transcode Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Transcode Therapeutics has no effect on the direction of EUDA Health i.e., EUDA Health and Transcode Therapeutics go up and down completely randomly.

Pair Corralation between EUDA Health and Transcode Therapeutics

Given the investment horizon of 90 days EUDA Health Holdings is expected to under-perform the Transcode Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, EUDA Health Holdings is 2.52 times less risky than Transcode Therapeutics. The stock trades about -0.06 of its potential returns per unit of risk. The Transcode Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  1,181  in Transcode Therapeutics on April 28, 2025 and sell it today you would lose (7.00) from holding Transcode Therapeutics or give up 0.59% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

EUDA Health Holdings  vs.  Transcode Therapeutics

 Performance 
       Timeline  
EUDA Health Holdings 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days EUDA Health Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Stock's fundamental indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Transcode Therapeutics 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Transcode Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Transcode Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

EUDA Health and Transcode Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with EUDA Health and Transcode Therapeutics

The main advantage of trading using opposite EUDA Health and Transcode Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if EUDA Health position performs unexpectedly, Transcode Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Transcode Therapeutics will offset losses from the drop in Transcode Therapeutics' long position.
The idea behind EUDA Health Holdings and Transcode Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Money Managers
Screen money managers from public funds and ETFs managed around the world
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum